Constellation Brands (STZ): Readthrough From Canopy Growth's Analyst Day - JPMorgan

JPMorgan analyst, Andrea Teixeira, reiterated her Overweight rating on shares of Constellation Brands (NYSE: STZ) after attending Canopy Growth’s (WEED) Analyst Day shortly after the company announced it intends to increase its stake to 38% (assuming warrant exercised) with a path to full control in the next three years.

The analyst stated "Although there was nothing specific related to STZ’s financial outlook, we came away encouraged about the potential growth of the industry in the coming years in Canada and were very impressed by the company’s products and operations across both the recreational and medical cannabis segments". No change to the price target of $260.00

For an analyst ratings summary and ratings history on Constellation Brands click here. For more ratings news on Constellation Brands click here.

Shares of Constellation Brands closed at $207.17 yesterday.

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating